Ameritas Investment Partners, Inc. Halozyme Therapeutics, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.86 Billion
- Q1 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 42,282 shares of HALO stock, worth $2.21 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
42,282
Previous 42,282
-0.0%
Holding current value
$2.21 Million
Previous $1.56 Million
10.12%
% of portfolio
0.06%
Previous 0.06%
Shares
19 transactions
Others Institutions Holding HALO
# of Institutions
441Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$955 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$683 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$340 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$216 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$199 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.29B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...